1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
Given its key role in the fight against COVID-19, the fact that (NYSE: PFE) shares are down 56% from their 2021 peak isn't entirely surprising. Demand for its COVID-19 vaccine (Comirnaty) and its treatment (Paxlovid) soared during the pandemic's height. With the coronavirus contagion abating in the meantime, though, last year's sales fell 41%. Income fell more than 70% year over year. Yikes.
However, the stock's sellers have arguably overshot their target. Pfizer stock is not only now well undervalued, but it's now sporting a big dividend yield of 6.2% as well.
That's a well-funded dividend, by the way, that's been raised every year for the past 15 years.
Source Fool.com
Pfizer Inc. Stock
€25.85
0.040%
With 31 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 41 € there is a hugely positive potential of 58.61% for Pfizer Inc. compared to the current price of 25.85 €.
